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                                                         SUMMARY 
 
Structures derived from natural products have led to discovery of numerous 
drug leads in modern-day drug development process. Here, we report a new class of 
compounds that we term Fc-metabolites, reported for the first time from a natural 
source. Complete structure of the first furanochromene (9H-furo [3,2–f] chromene; 
abbreviated as Fc-8b) and furanocoumarin (abbreviated as Fc-8f) are described based 
on 1H, 13C, 2D-COSY nuclear magnetic resonance spectroscopy and mass 
spectrometer. Furanochromenes are most related to the furanocoumarins class of 
compounds. We have developed their purification and identification procedures from 
the seeds of the legume plant, Psoralea corylifolia that is found commonly in Asia, to 
produce more than 99% pure compounds. More significantly, we report that these Fc-
metabolites are highly active in inducing proliferation of primary human skin cells at 
concentrations as low as 5 µM. The level of proliferation induced by these compounds 
is comparable to that by the universal standard 10% fetal calf serum (FCS) in the 
same time-period. We found that therapeutically, these compounds have wide range 
of applications but our initial study had few disadvantages such as, these compounds 
have short shelf-life period and the concentrations of the active compounds purified 
was very low. These disadvantages led us to the second part of our study. 
  
Availability of structural information from these two bioactive Fc-metabolites 
shows that the furan and pyran rings are involved in isomerisation. These provide a 
structural basis for synthesizing further synthetic bioactive furanochromenes (Fc-
compounds). Based on the available structure we have developed a novel scheme to 
synthesize furanocoumarins and furanochromenes. Using this scheme we have 
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synthesized two new furanocoumarin derivatives, of which one is active (Syn 1) and 
even better in inducing proliferation than natural forms reported here. The cellular 
level studies show that these bioactive drugs trigger the proliferations mechanism via 
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1.1 Natural Product Chemistry 
A natural product is a chemical compound or substance produced by a living 
organism - found in nature that usually has a pharmacological or biological activity 
for use in pharmaceutical drug discovery and drug design. A natural product can be 
considered as such even if it can be prepared by total synthesis. These small 
molecules provide a template or skeleton for the majority of FDA-approved agents 
and continue to be one of the major sources of inspiration for drug discovery. In 
particular, these compounds are important in the treatment of life-threatening 
conditions (Dudler, R et al. 2008). 
Plants have always been a rich source of lead compounds some of the classic 
examples are morphine, cocaine, digitalis, quinine, tubocurarine, nicotine, muscarine 
and didemnin. Many of these lead compounds are useful drugs by themselves (e.g. 
morphine and quinine) while others have been the basis for synthetic drugs (e.g. local 
anaesthetics developed from cocaine). Plants provide a large bank of rich, complex 
and highly varied molecular structures that are unlikely to be synthesized 
in laboratories. Furthermore, evolution seems to have already carried out a selective 
process whereby plants survival increase based on the presence of anti-herbivory 
compounds. Such products deter animals or insects from foraging on plants. Despite 
these benefits of plant-derived compounds, the number of plants that have been 
extensively studied is relatively very few and the vast majority of plant species have 




1.2 Plant-Derived Furanocoumarins and Furanochromenes:  
Furanocoumarins, or furanochromenes, are a class of organic chemical 
compounds produced by a variety of plants. They are biosynthesized partly through 
the phenylpropanoid pathway and the mevalonate pathway, which is biosynthesized 
by coupling of dimethylallyl pyrophosphate (DMAPP) and 7 
hydroxycoumarin (umbelliferone) (Keggs, 2001) (Figure 1.1 and Figure 1.4). The first 
step in the bergapten biosynthetic pathway is the C-alkylation of the ortho-carbon to 
phenol. Subsequently, a series of oxidative enzymatic reactions take place.  
Benzopyran is an polycyclic organic compound that results from the fusion of 
a benzene ring to a heterocyclic pyran ring. According to IUPAC nomenclature it is 
called chromene. An additional furan ring attached to chromene becomes 
furanochromene. Furanochromene also belong to the same class Furanocoumarin as 
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Figure 1.1: Biosynthetic coupling of Dimethylallyl pyrophosphate (DMAPP) 
and 7 hydroxycoumarin (umbelliferone) giving rise to furanocoumarins 
 
The chemical structure of furanocoumarins consists of a furan ring fused 
with coumarin. The furan may be fused in different ways producing several isomers 







Coumarin Structure: Coumarin is a precursor of furanocoumarins
Psoralen Structure: A linear furanocoumarin. Angelicin Structure: An angular furanocoumarin.
These are precursor to many members of furanocoumarin family.
 
Figure 1.2: Basic structures of Psoralen and Angelicin 
 
The compounds that form the core structure of the two most common isomers 
are Psoralen and Angelicin (Fig 1.3). Derivatives of these two core structures are 











































Many furanocoumarins are toxic and are produced by plants as a defence 
mechanism against various types of predators ranging from insects to mammals 
(Verpoorte, 1998) .This class of phytochemical is responsible for 
the phytophotodermatitis seen in exposure to the juices of the wild parsnip. 
Furanocoumarins have other biological effects as well. For example, in 
humans, bergamottin and dihydroxybergamottin are responsible for the "grapefruit 
juice effect", in which these furanocoumarins affect the metabolism of certain drugs 
(Tsai et al, 1995) 
1.3 General characterization of Psoralea corylifolia  
Psoralea corylifolia is a leguminous plant that is commonly found in China as 
bu gu zhi (Zhao et al, 2005), India as babchi and in Southeast Asian countries 
(Matsuda et al, 2007). It has been used as traditional medicine in India and China for 
several skin diseases such as psoriasis, leucoderma, and vitiligo (Sathe et al, 
2010).Various parts of P. corylifolia plant have different medicinal values. For 
example, the root is useful in treating the caries of the teeth and it is also used to 
promote bone calcification, making it useful for treating osteoporosis and bone 
fractures (Joshi, 2000). Leaves are used to alleviate diarrhoea and fruit extracts are 
used in treating piles, bronchitis, and anemias (Kong et al, 2007). The seeds are anti 
pyretic and alexiteric. The seed extracts are known to have various anti-microbial 
activities such as, inhibiting the growth of Staphylococcus citrates, Staphylococcus 
aureus, Staphylococcus albus, including strains resistant to penicillin and other 
antibiotics. Psoralen inhibits bacteria such as Microsporium canis, Micrisporium 
gypseum, Trichophyton rubrum, Trichophyton mentagrophytes, S, aureus, Candida 
albiacans, Escherichia coli, P. Aeruginosa (Sathe et al, 2010) 
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Psoralea corylifolia has immense biological importance to man and it has 
been widely exploited for its miraculous effect on several skin diseases like psoriasis, 
leucoderma, leprosy, and illness such as enuresis, pollakiuria, painful feeling of cold 
in the waist or knees and weak kidney. Studies have shown that these seeds consist of 
broad biological activities such as cytotoxicity, antimutagenic, bone calcination, anti-
inflammatory, antibacterial, antifungal, antifeedant and antirepellant (Sah P et al, 
2006). Vitiligo is an acquired cutaneous depigmentation disorder which is associated 
with loss of melanocytes from the basal layer of epidermis and it was reported that 
patients underwent six months of Psoralea treatment regained pigmentation and were 
cured. Besides, psoralens, components in Psoralea cause residual pigmentation when 
applied on hypo-pigmented skin, together with increased blood flow and melanin 
producing activity in the affected area (Jean-paul Ortonne, 1989). In view of these 
numerous therapeutic effects of Psoralea seed, it is of great interest to further 
investigate new constituents in the seed and examine its bioactivity on skin fibroblast. 
1.4 Seed Constituent analysis 
Psoralea corylifolia contain several important chemical constituents. One of 
the main groups of constituents is coumarins which include psoralen or isopsoralen 
while another group is flavones which include neobavaisoflavone, corylin, bakuchiol, 
bavachinin, bavachin and isobavachalcone which are antioxidative. 
 Studies have shown that the seeds of P. corylifolia contain several important 
chemical constituents including coumarins and flavones such as psoralen, isopsoralen, 
psoralidin and bavachalcone (Zhao et al, 2005). Psoralen and isopsoralen are the main 
coumarins components of P. corylifolia (Liu et al, 2004). Psoralia extracts and 
psoralen have been used in the treatment of psoriasis. The most common form of 
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psoriasis is chronic plaque psoriasis and is characterized by red, heavily scaled, well 
demarcated plaques on elbows, knees, scalp, and lower back, although any skin 
surface may be involved predominating in the epidermis (Cumberbatch et al, 2006). 
In view of the numerous potential applications of compounds from Psoralea and 
presence of many modified coumarin-derivatives in Psoralia, we investigated the 
effects of seed methanolic extracts and its components on human primary skin cells.  
Other constituents of the seeds include bovachin, bavachromene, psoralidin, 
isobavachalcone, bavachinin and bavachalcone. It has also been reported that there 
are two unknown constituents of the seeds that are yet to be identified (Zhao et al., 
2005b). The distribution of these constituents in the plants generally occurs at the 
highest level in the fruits followed by roots, stems and leaves (in order of decreasing 
occurrence). In addition, seasonal changes and environmental conditions may affect 
the occurrence in various parts of the plant (O’Kennedy and Thornes, 1997). Psoralea 
corylifolia provides a good source of furanocoumarins and has been used in Indian 
and Chinese medicine in the treatment of many diseases such asenuresis, pollakiuria, 
painful feeling of cold in the waist or knees and weak kidney (Zhao et al., 2005b). 
More importantly, it has also been used in the treatment of skin diseases such as 
psoriasis and vitiligo (Zhao et al., 2005a). The most common form of psoriasis is 
chronic plaque psoriasis and is characterized by red, heavily scaled, well demarcated 
plaques on elbows, knees, scalp, and lower back, although any skin surface may be 
involved predominating in the epidermis (Cumberbatch et al, 2006). 
P. corylifolia, an herbaceous plant was chosen in this project because it has 
been used as traditional medicine in India and China for several skin diseases like 
psoriasis, leucoderma, vitiligo etc. The objective of this work is to extract and purify 
compounds from the seeds, characterize it and further test their biological effects on 
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primary human skin fibroblast cells. Here, we have identified two peaks in RP-HPLC 
which have immense biological effects, namely peak 8b and peak 8f. Compound Fc-
8b and Fc-8f were successfully characterized from peak 8b and 8f. Here, compound 
Fc-8b has been characterized as novel chromene derivatives and Fc-8f was a novel 
furanocoumarin derivative and both of them, show significant effects on cell 
proliferation, to the levels comparable to effects of growth factors or fetal calf serum.  
1.5 A link between natural and synthetic worlds 
Natural product research has been traditionally defined within different 
research sectors that include: isolation, elucidation, activity screening, chemical 
synthesis and biosynthesis. Often these studies are conducted by independent 
laboratories whose research is focused on one aspect of the process, such as natural 
product isolation or total synthesis (J. C. Venter et al. 2001) 
This process usually begins with an extract or culture. Natural product 
isolation is a difficult task given the complexity of marine and terrestrial extracts. A 
number of techniques, including bioactivity-guided methods, high-throughput 
screening and fraction library guided approaches, now exist to index the components 
of an extract. While vital tools, these approaches often fail to provide feedback as to 
the role their structures play in delivering a unique mode of action (MOA) (E. S. 
Lander et al. 2001). Related structures of natural products can help to identify active 
centres in the structure and guide in designing of synthetic analogues. 
1.6 Mode of Action: 
MOA refers to an event in which a small molecule regulates a specific 
biological process. This phenotypic effect is a complex multilevel process that has 
specific mechanistic considerations that are encoded at the level of the atom (as in 
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molecular structure), molecule (as in targeting and signalling), cell, tissue, organism, 
and ecosystem. 
Within their compact uniquely organized motifs, natural products contain a 
‘‘structural code’’ that allows them to target a specific biological molecule or bio- 
molecular interaction. Regulation of these binding events is then translated into a 
phenotypic modification that arises either at the level of the cell (e.g., a blockage in 
mitosis), organism (i.e., limb development), or ecosystem (i.e., chemical defence). It 
is within these fundamental connections between molecular signals and their 
phenotypic responses that define a molecule’s MOA. The connection between these 
different experimental approaches (e.g., combining molecular target elucidation with 
cellular microscopy) adds complexity to MOA research. To make matters confusing, 
the term mechanism of action (also MOA) is used interchangeably within the 
literature 
Understanding the MOA of a natural product often requires a delicate balance 
between multiple research sectors. For instance, the complement between natural 
isolation and chemical synthesis is key to develop analogues that allow one to further 
probe the activity of a compound, while activity screening and biosynthesis are key to 
guiding MOA studies and compound production. To tackle this diversity, laboratories 
are faced with either expanding their research focus to integrate aspects of cell and 
molecular biology into their natural product and synthetic organic chemistry cores, or 
they develop collaborations. Within the last decade, collaborative programs have 
provided a leading force in the elucidation of natural product activity (M. E. Maier, 
2009). Such studies have led the way in MOA studies, as well as for methods 
development. All the components that give a total picture of MOA are summarized in 









Figure 1.5: The components of natural product research are divisible into 
sectors, including: isolation and structure elucidation (orange), activity screening 
and biological studies (red), chemical synthesis (yellow), biosynthesis (blue) and 
analogue preparation (green) (Clair, 2009) 
 
1.6.1 Synthetically - enabled Mode of Action: 
In addition to advances in isolation, elucidation and biological evaluation, 
support for synthetic organic chemistry is vital to the further understanding of natural 
product biology. The following section provides a brief overview of the interplay 
between chemical synthesis (total synthesis) and the understanding of natural product 
activity. 
1.6.2 A vital role for total synthesis 
While the synthetic community often focuses on the development of chemical 
methods and synthetic approaches, total synthesis also has several fundamental roles 
in MOA science. First, it serves as a vital tool to confirm (or revise) the structural 
assignments (Butler, M.S. 2008). Second, it provides access to materials that may not 
be readily available. Finally and perhaps most importantly, it provides access to probe 
and probe classes that cannot be accessed naturally. The importance of MOA work 
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has become a common theme in natural product total syntheses, with a large majority 
of the total syntheses in the period of this review stating the importance of providing 
access to subsequent MOA and activity studies; salient examples include 
amphodinolides, (+)-acutiphycin, the bryostatins, chlorosulfolipid cytotoxins, 
diazonamides etc (Newman, D, J and G. M. Cragg, J. 2007) 
1.7 Assays for Cell Viability and Proliferation  
Cell proliferation assays are particularly valuable in medical research and drug 
development. Examples include chemically induced mutagenicity and carcinogenicity 
assays, the screening of novel growth and differentiation factors and the detection of 
oestrogenic compounds (Kintzios, 2005). In this project, tetrazolium-based 
colorimetric assay (MTS test) has been used to determine the cell proliferation under 
influence of specific compound found in Psoralea corylifolia seeds.  
The in vitro MTS test was first described by Promega which is a modification 
of the MTT assay, to detect mammalian cell survival and proliferation. It is a rapid 
colorimetric method based on the cleavage of yellow tetrazolium salt (3-{4, 5-
dimethylthiazol-2-yl}-2, 5-diphenyl tetrazolium bromide) to purple formazan 
precipitate by mitochondrial dehydrogenases enzyme of metabolically active cells. 
Given that the total amount of formazan generated in the plate is directly proportional 
to the number of viable cells, this method has been adopted largely for its rapidity and 
accuracy in measuring cell survival and proliferation (Fig 1.6) (G. Ciapetti et al, 
1993).  
                    
Figure 1.6: Scheme showing the reduction of MTT to formazan
 
However, when applying MTT test, several cautionary steps need to be 
observed as catechols and flavonoids, quercetin
serum supplemented medium that could resulted in false readings on the 
spectrophotometer. Antioxidant effects of plant extracts such as 
fibroblast cells were also observed (Phan et al 2000). These issues
using MTS reagent. It must be noted that MTT and MTS have the same chemical 
structure. MTS assay reagent contains 
all other constituents found in MTT assay reagent
1.8 Potential Application of Fu
Wound healing is a complex and dynamic process of restoring cellular 
structures and tissue layers. The human adult wound healing process can be divided 
into 3 distinct phases: the inflammatory phase, the proliferative
remodeling phase. Within these 3 broad phases is a complex and coordinated series of 
events that includes chemotaxis, phagocytosis, neocollagenesis, collagen degradation, 
and collagen remodeling.
 
 were found to reduce the MTT in 
Buddleja globosa 
 are removed on 
phenazine methosulfate (PMS) in addition to 
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ranocoumarins in Wound Healing Process








In diabetic wounds or diabetic ulcers, however, healing impairment occurs. 
One important characteristic of diabetic wounds in relation to this project is that some 
of the resident cells in diabetic foot ulcers become phenotypically altered. Fibroblasts 
isolated from diabetic foot ulcers are probably senescent and show a decreased 
proliferative response to growth factors (Loots et al, 2002). Evidence suggests that 
phenotypic changes in wound cells are not due only to replicative senescence, but are 
perhaps caused by more complex interactions between the resident cells and the 
chronic wound. Although there is no direct evidence that the proliferative activity of 
keratinocytes is affected in diabetes, migration of these cells is likely to be impaired 
(Falanga, 2005). 
Therefore, the availability of natural product derived compounds that can 
increase proliferation in human skin cells such as fibroblast and keratinocytes may be 
therapeutically useful in the process of wound healing, not just in healing diabetic 
wounds, but also other types of wounds such as burns. 
1.8.1 Coumarin-derived natural products 
Coumarins are often found as secondary metabolites that play role in plant 
defense due to various stress events in plants (Zobel, 1997). They belong to 
benzopyrones, a group of compounds where a benzene ring is joined to a pyrone. A 
pyrone is a six member heterocyclic ring, containing one oxygen atom and a five sp
2 
hybridized carbons. This compound has numerous bioactivities and serves as skeleton 
for a number of commercially available drugs used for psoriasis, anticoagulants, high 
protein oedema and many other conditions (O’Kennedy and Thornes, 1997). In spite 
of all these positive effects, there are no reports of mitogenic action which is crucial in 
cell division and proliferation.  
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Furanocoumarins such as xanthotoxin and bergapten, whose biogenetic 
precursor is umbelliferone, belong to a subclass of the coumarin family. It consists of 
a five member furan ring attached to the coumarin nucleus which can be either 
psoralen or angelicin. Different ways and angles of furan binding to the core structure 
will then give rise to different isomers.  
Furanocoumarins are products of the shikimate pathway which is the 
biosynthetic route for aromatic amino acids biosynthesis and this subclass of 
compounds are derived from precursors such as coumaric acid and umbelliferone. 
‘Linear’ furanocoumarins were form when the furan rings in line with the benz-2-
pyrone nucleus; while ‘angular’ furanocoumarin are those where the furan ring is 
oriented at an angle to the nucleus. Furanocoumarins are of pharmaceutical interest 
because of their numerous biological activities and this compound plays an important 
role in natural compound-derived drugs in therapies as skin repigmentation 
stimulants. 
1.9 Aims of this project  
This project aims to extract, separate, identify and purify novel compounds 
found in seeds of Psoralea corylifolia. These compounds were characterized and 
tested for their biological activities on human primary skin cells. A synthetic pathway 
was designed and used to synthesize the bio-active forms of naturally isolated 
compounds. A comparative bioactive study was done to see if the synthetic 
compounds emulate similar activity as naturally isolated compounds. Further, cell 
cycle analysis using flow cytometry and confocal imaging were done to identify the 




















The Materials and Methods section encompasses detailed descriptions of all 
the methods employed and the protocols followed while performing the experiments. 
It also provides the source of all reagents and biological materials used in the 
research. 
 
Figure 2.1 summarizes the experimental approaches applied in this project in 
order to investigate the effects of the selected constituents of the seeds of Psoralea 




Figure 2.1: Outline of experimental approaches to investigate the effects of 





2.1 Seed Processing  
2.1.1 Seed Extraction  
Psoralea corylifolia seeds were collected from Tiruchirappalli, Tamil Nadu, 
India. 100mg of seeds were frozen in liquid nitrogen and ground into fine powder, and 
then homogenized in 1ml of 80% methanol (HPLC graded) to extract the hydrophobic 
metabolites. This homogenized mixture was then centrifuged at 14,000rpm for 
30minutes at 4°C. Supernatant was collected and filtered using 0.2µ filter to obtain 
homogenous crude sample. The samples were stored at 4°C in darkness.  
 
2.1.2 Reverse Phase High Performance Liquid Chromatography (RP-HPLC) 
using Analytical Column  
 
The HPLC system used was ÄKTA purifier 
TM 
10 from Amersham 
Biosciences. In this chromatographic analysis, Jupiter 
TM 
5µm C18 300 Å analytical 
column with the dimension of 250 x 4.6mm from Phenomenex, Inc., USA, was used. 
100µL of methanolic crude sample was injected for the analytical run. A linear 
gradient elution method using two buffers: Buffer A (water-acetic acid at pH3; 
5ml/250ml of water) as aqueous solvent and Buffer B (100% Acetonitrile) as organic 
solvent, was carried out. All buffers that were used in HPLC must be HPLC graded 
and filtered with membrane filter with a pore width of 0.2 µm. An elution profile with 
A: B ratio – 0 min. 100:0; 60 min. 40:60; 66min. 0:100 were performed. Following 
that, isocratic elution with 100% Acetonitrile was carried out for 5 min. The flow rate 




2.1.3 Scale up of RP-HPLC using Semi- Preparative Column  
Fivefold scale up was carried out using Jupiter 
TM 
5µm C18 300 Å with 
dimension 250 x 10.00 mm semi-prep column. The HPLC system used was ÄKTA 
purifier 
TM 
10 from Amersham Biosciences. Here, volume injected for the whole run 
was 900µL but it breaks down to a total of 9 injections because the loading loop 
capacity was 100 µL. A linear gradient elution method using Buffer A (water-acetic 
acid at pH3) and Buffer B (100% Acetonitrile) was carried out in the following A: B 
ratio. 0min, 100:0 ; 50min, 60:40 ; 95min, 52:48 ; 105min, 36:64 ; 115min, 0:100 ; 
118min, 0:100 ; 118.5min, 100.0; 120min, 100:0. The flow rate was increased to 
2.363ml/min and the detection wavelength of 254nm was set. During elution, 
fractions of 1ml per tube were collected between 52min and 55min of elution 
(collection of compound A) and then 1.5ml per fraction (tube) between 72 min and 
96min (collection of compounds from 8a to 8f). Fractions of each peak that were 
collected were labelled and store in 4’C fridge under dark conditions. 
2.2 Purifying and characterizing compound 8b  
2.2.1 Extraction of solvent from compound 8b by lyophilization  
The fraction 8b collected from HPLC fraction from ~78min to 81min time 
point was lyophilized to get rid of the solvent which were acetic acid and acetonitrile. 
The samples were collected in falcon tube, filling it up to one third of the tube 
capacity. Then, the tubes were freeze at -80°C fridge in an inclined position at about 
140° until solidification. After freezing the samples, they were sent for lyophilization 
at Protein and Proteomics Center (NUS). The freeze-dry process took at least 15hours 
to obtain the pure solid 8b compound.  
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2.2.2 Purification of compound 8b by rotavapor  
Because each tube that sent for lyophilization will only consist of ~15mL of 
fraction 8b, amount of solid form of 8b that were collected were minute and ‘sticked’ 
on tube surface. All these pure solid form of 8b have to be concentrated in one sample 
tube in order to perform further characterization test such as mass spectrometry and 
NMR. Samples were ‘washed’ in filtered methanol (about 5mL per tube) to dissolve 
all solid 8b sample. These entire dissolved samples were then collected in a 25mL 
round bottom flask and underwent rotavapor, setting temperature at 40-45°C to 
extract excess methanol. The process will be stopped when dry samples which are 
brownish yellow were seen. 
 
2.2.3 Structural analysis using Mass Spectrometry  
Solid sample were then dissolved in 1ml of MeOD4 and sent for mass analysis 
with electronspray ionization (ESI) source. Mass spectra were acquired by a 
Micromass VG7035 double focusing mass spectrometer of high resolution. The 
ionization mode selected was positive. The masses of positive ion species within the 
range of 0- 500 amu were detected in ESI-MS experiments.  
 
2.2.4 Nuclear Magnetic Resonance  
10mg of pure solid compound 8b was used for NMR structural analysis to 
examine its chemical environment. Four different types of analysis which are 1H 
NMR, 13C NMR, COSY, and HMQC were carried out. NMR spectra were recorded 
on a Bruker AMX 300 spectrometer. The solvent used were DMSO-d6, MeOD4. 
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2.3 Purifying and characterizing compound 8f mixture  
2.3.1 Sample preparation for RP-HPLC for further analysis  
Sample obtained from HPLC fractions 8f were lyophilized as described in 
Section 2.2.1. Solid form (yellow powder) compound 8f mixtures were dissolved in 
filtered methanol as described in Chapter 3. 
2.3.2 Further analysis of compound 8f mixture by RP-HPLC  
In this chromatographic analysis of compound 8f mixture, Synergi Polar 
TM 
RP 4µm 80 Å, (250 x 4.6mm) analytical column obtained from Phenomenex 
Company were used and was performed on ÄKTA purifier 
TM 
10 from Amersham 
Biosciences. With this column, many optimization trials were carried out to get the 
perfect elution profile with highest resolution. The injection volume for each 
analytical run is 100µL. For aqueous mobile phase, water-acetic acid pH3 were used; 
while different mixture ratio of methanol and acetonitrile were used for organic 
mobile phase. In this optimization process, the elusions were started with 100% 
methanol and then increasing addition of acetonitrile was tried. Besides optimizing 
the mobile phase as one of the parameter, different flow rate were also been tested so 
that the time required for separation of 8f mixture can be as short as possible.  
 
2.3.3 Further analysis of compound 8b and 8f mixture by simple, small scale thin 
layer chromatography (TLC)   
Sample Fc-8b and Fc-8f were deposited as a spot on the stationary phase 
which is 5 X 2cm silica gel plate. Combination of 70% hexane and 30% of ethyl 
acetate were used as mobile phase to provide adequate selectivity for the 8f mixture to 
be separated. When the solvent reached the front, the plate was visualized under a UV 
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lamp. For better visible result, the plate was placed in iodine chamber for 8-10 
minutes. 
2.3.4 Scale up of TLC by using Preparative TLC  
2.3.4.1 Depositing sample 8b and 8f mixture on TLC plate  
Silica gel 60 F
254 
preparative TLC plates (20×20 cm with 4×20 cm 
concentration zone, 0.5 mm layer thickness and fluorescence with excitation 254 nm) 
(Merck) was used as the stationary phase in this preparative TLC. A band of 8f 
sample pre-dissolved in methanol was deposited on the plate with a glass pipette. 
Then, hexane: ethyl acetate in the ratio 70:30 (v/v) was used as the mobile phase. This 
preparative TLC were carried out in flat bottomed 20x 20cm TLC chamber and 
100mL of mobile phase solvent were poured in. Then, the 20x 20 TLC plate with 
sample were placed carefully inside the chamber and the separation process started. 
Throughout the whole run, careful inspection was done with the aid of UV lamp to 
monitor the separation and band length of each compound found in 8f mixture.  
 
2.3.4.2 Identification and collection of different compound on TLC plate  
Three bands were detected on the preparative TLC plate. Then blue fluoresce 
band which has longer band length were identified under aid of UV light and scraped 
out using a TLC plate scrapper. The flakes were then collected in a 250mL con flask 
and dissolved with dichloromethane to extract the interest compound. Sonification 
method was used as well to ‘knock-out’ compound that bound to the silica gel. Then, 





2.4 Investigation on effects of compound 8b and 8f on skin fibroblast  
2.4.1 Maintenance of Skin Fibroblast Cells  
Human skin fibroblast cells (NF103) were used for this project. Human skin 
fibroblast cells (obtained with courtesy of Dr. Phan Toan Thang, Department of 
Surgery, Faculty of Medicine, NUS) were cultured in Dulbecco’s Modified Eagle 
Medium (DMEM); supplemented with 10% fetal bovine serum (FBS; Hyclone 
® 
, 
Research Grade and 1% v/v antibiotic antimycotic solution. All human skin fibroblast 
cells were incubated at 37ºC in CO2 incubators which maintains a humidified 
atmosphere of 5% CO2 / 95% room air. Human skin fibroblast cells were cultured in 
culture flasks. Cells were passaged when confluent by removing spent medium, 
washing with 1 x phosphate buffered saline (PBS), dislodging with 2mL Trypsin and 
adding fresh medium to inactivate the Trypsin and dilute the cells before distribution 
into new culture flasks for growth.  
 
2.4.2 Seeding of fibroblast cells into 96 multiwell plate  
Human dermal fibroblast cells were seeded in 96 well plates at a density of 1 
x10
6
cells / well in complete DMEM basal medium (contained 10% Fbs and 1% v/v 
antibiotic). After 48 hours, each well was washed with PBS buffer. DMEM with 
different concentration of compound 8b, compound 8b + compound 8f were added. 
For the experiments, seeded blank wells were added with DMEM as control 1 and 
DMEM with solvent compound control 2. Each well was loaded with 300µL of 




2.4.3 Qualitative investigation of fibroblast cells  
After 24, 48 and 72hrs cells were viewed under microscope and pictures were 
taken to compare their proliferation rate.  
 
2.4.4 MTS proliferation assay  
5mg/mL of MTS stock solution were prepared by dissolving MTT powder in 
PBS. Then, 15% of MTT stock solution diluted in DMEM was added into each well 
and incubated for 4 hours at 37ºC. The plate should be wrapped with aluminum foil to 
avoid blocking the light as MTS is light sensitive. Absorbance at 490nm of each well 
was then measured by a microplate ELISA reader.  
2.4.5 Compound 8b and compound 8f drug preparation  
Both compounds extracted from Psoralea corylifolia are hydrophobic 
compounds which needs organic solvent to dissolve. To create drug concentration 
with 5µM and 10 µM, a standard graph was plotted using psoralea as the standard 
compound and different milligrams of sample were injected into HPLC to get a linear 
intensity peak. Then, this standard graph will be the reference on how many moles of 




2.5 Synthesis of Furanocoumarins: (all reagents were brought from Sigma-
Aldrich) 
2.5.1 Methods for Synthesis of Furanocoumarins 
2.5.1.1 Step 1: Ethyl coumarin-3-carboxylate derivatives  
To a solution of 2-hydroxybenzaldehydes (3 mmol) in diethyl malonate (3 
mmol) was added piperidine (10 drops), and the resulting solution was stirred for 30 
minutes at room temperature. Then it was acidified with a solution of 10% HCl. The 
precipitate material was filtrated and washed with cold water. The desired products 
were purified by recrystallization from ethyl acetate or flash chromatography. 
 
2.5.1.2 Step2: Ethyl 8-bromo-7-hydroxy-2-oxo-2H-chromene-3carboxylate. 
To a solution of coumarin (570 mg, 2.41 mmol) in glacial acetic acid (16 mL) 
at 60 ‘C was added slowly a solution of bromine (0.13 mL, 2.65 mmol) in acetic acid 
(1mL). The mixture was stirred for 3 h, then the temperature was allowed to rise to 
room temperature and the precipitate was filtrated, washed with cool water and dried 
under vacuum giving coumarin. 
2.5.1.3 Step 3: Sonogashira reaction procedure:  
Ethyl 8-bromo-7-hydroxy-2-oxo-2H-chromene-3-carboxylate (4.73 g, 18.1 
mmol, 1.0 equiv), CuI (1.72 g, 9.06 mmol, 0.5 equiv), [PdCl2(PPh3)2] (3.18 g, 4.53 
mmol, 25 mol %), Et3N (10.1 mL, 72.5 mmol, 4.0 equiv) and 2-methylbut-1-en-3-yne 
(6.9 mL, 72.5 mmol, 4.0 equiv) in 72 mL of DMF was heated at 60 ‘C under N2 
atmosphere for 3 h. The mixture was then diluted with Et2O, washed twice with 5% 
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aq HCl solution and saturated aq. NaCl solution, dried over MgSO4, and 
concentrated. Purification by flash chromatography on silica gel was performed. 
2.6 Spectroscopic Characterization:  
1H (300 MHz), 13C (75MHz) 2D COSY, NMR spectra were recorded on a 
Bruker AMX 300 spectrometer. Mass spectra were acquired by a Micromass VG7035 
double focusing mass spectrometer of high resolution. The UV-Vis spectra were 
measured on a Shimadzu UV-1601 PC spectrophotometer, and MTS assay 
absorbance measurements were carried out on a TECAN Infinite 200 PRO 
spectrophotometer. 
2.7 Cell Cycle Analysis  
We used flow cytometry analysis to study the change in the cell cycle 
distribution of the cells after drug treatment. The cells were treated with Fc-8b, Fc-8f 
and Syn1. Time points of 24 h, 48 h, 72h, were adopted for the study. The cells were 
washed twice with 1X PBS and fixed in ice cold 70% ethanol. The fixed cells were 
then stored at -20˚C until staining and analysis. The cells were stained with staining 
solution containing 0.1% Triton-X-100 in PBS, 200 µg/ml of RNaseA and 20 µg/ml 
of propidium iodide (PI) for half an hour before flow cytometry analysis. The DNA 
content of the samples was studied by running the samples on Guava Flow Cytometer. 
50,000 relevant cells were collected in each sample. The DNA content distribution 
was obtained by analysis using the Summit 4.3 software. 
2.8 Confocal Imaging: 
LSM 510 Meta, Carl Zeiss was used to take the images. Cells were harvested 
on cover slips. The cells were treated with Fc-8b, Fc-8f and Syn1. Time points of 24 
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h, 48 h, 72h, were adopted for the study. The cells were washed twice with 1X PBS 
and fixed in ice cold 70% ethanol. The fixed cells were then stored at -20˚C until 
staining and analysis. The cells were stained with staining solution containing 0.1% 
Triton-X-100 in PBS, 200 µg/ml of RNaseA and 20 µg/ml of propidium iodide (PI) 




















Results and Discussion 
 
Isolation, Purification and Structural 
Elucidation of 9H-furo [3, 2-f] chromene 
and coumarin derivatives from Psoralea 
corylifolia seeds that induce proliferation 









Natural-product structures present wide chemical diversity, biochemical 
specificity and other molecular properties which make them excellent lead structures 
for drug discovery. The valuable compounds may subsequently be chemically 
synthesized in their original structure for therapeutic purposes, or derivatives of those 
compounds may be developed to further improve their pharmacological effectiveness. 
Plants, in particular, have provided a great variety of secondary metabolites which 
have been sources of commercially important pharmaceutical compounds. Numerous 
chemotherapeutic agents used nowadays were obtained chiefly from plants (Uriarte et 
al, 2005).  
3.1 Purifications of Fc-Compounds Using Reverse Phase HPLC 
Consistency in the HPLC profiles generated clearly indicates that Reverse 
Phase HPLC allows the achievement of good separation with narrow symmetrical 
Peaks. Hydrophobic interactions occur between the hydrophobic metabolites and the 
octadecyl chain that are covalently bound to the silica beads packed in the column. 
The retained metabolites were eluted out according to their hydrophobicity in 
response to an increasing gradient of organic solvent acetonitrile. In this experiment, 
no peaks were observed before and after the elution gradient was applied, where an 
isocratic elution of 100% acetonitrile only results in a few metabolites was being 
eluted out. These results suggest that the metabolites were successfully bound to the 
column and metabolites were eluted out during the elution gradient. Less hydrophobic 
or more polar metabolites would be eluted out during the early phase of the elution 
gradient while the more hydrophobic metabolites would be eluted later in the 
gradient. The wavelength of 254nm was selected based on the method used in the 
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paper by Lee et al (2005) where they used this wavelength to evaluate the purity of 
coumarin-related compounds extracted from seeds of P. corylifolia such as 
bavachinin (Simonian, A. 2005) and bavachalcone (Gorzen, W, 2003). Scale-up of the 
HPLC process was necessary to ensure that enough purified compounds are available 
for subsequent MTS-based proliferation assay experiments, as well as for the 
structural analysis of novel compounds.  
 
RP-HPLC extraction of methanolic extracts of seeds from P. corylifolia was 
carried out following the isocratic elution profile. This elution gradient was adapted 
from Rafidah Bte Abdul Mutalif (previous honors student). The flow rate was 0.5 
ml/min and the compounds were detected at wavelength of 254nm. One ml fraction 
was collected per minute during the elution period. The RP-HPLC profile generated 
12 significant peaks as shown in Figure 3.1. The retention time at which the twelve 
peaks occur are shown in Table 4.1. RP-HPLC extraction of methanolic extracts of P. 
corylifolia seeds was scaled up to allow the collection of more samples needed. The 
flow rate was increased to 2.363 ml/min and the compounds were detected at 
wavelength of 254nm. 2.363 ml fraction was collected per minute during the elution 
period. Similar to the profile generated by the analytical column, the RP-HPLC 
profile of the semi preparative column generated 12 significant peaks as shown in 
Figure 3.1.  The bioactivity studies were performed for all the 12 peaks (Chan Jai hui, 
2008) out of which two of the RP-HPLC fractions were determined to poses 
bioactivity. These two fractions occur at Peak 8b and Peak 8f of the RP-HPLC 
chromatograms in Figure 3.1. RP-HPLC fractions from Peak 8b and Peak 8f were 
collected and concentrated by lyophilisation technique for in vitro screening assay 




     
 
Figure 3.1 (a): RP-HPLC chromatogram of methanolic seed extracts of P. 
corylifolia seeds. X axis: elution volume (mL); y axis: UV signal intensity 
(arbitrary absorbance units at 254nm). The elution profile is shown in green. (b): 
Enlarged view of the chromatogram zone containing the compounds of the 








































3.2 Further purification of Fc-8b and Fc-8f using preparative Thin Layer 
Chromatography (TLC) technique. 
 
TLC was carried out for further analysing the purity of the fractions from the 
peaks 8b and 8f. Preparative TLC and flash chromatography were performed to obtain 
99% purity of compounds. 
                          
Figure 3.2: Preparative-TLC of Fc-8b and Fc-8f deposited on TLC plate. 
 
Table 3.2: Retention factor calculated for compound Fc-8b. 3 separate 
experiments were carried out for each sample. 






1st set 2.5 6.2 0.40 
2nd set 2.9 6.4 0.45  








Table 3.3: Retention factor calculated for compound Fc-8f. 3 separate experiments 
were carried out for each sample. 
Yellow, minor 
band 






1st set 4 6.4 0.62 
2nd set 3.8 6.4 0.59 
3rd set 3.5 6.2 0.56 
 
3.3 Quantification of the compounds Fc-8b and Fc-8f 
From Spectroscopic studies the molecular weight of Fc-8b and Fc-8f was 
determine to be 173.1dal and 336.4dal respectively. 
Approximately 5mg of Fc-compounds of 99% purity was obtained from 
100ml of the methanolic seed extract. Thus calculating the no. of moles.  
Fc-8b = 5mg/173.1g = 28.8 moles 
Fc-8f = 5mg/336.4g = 14.8 moles 
3.4 Structural elucidation of Compound Fc-8b and Compound Fc-8f  
 
1H, 13C, 2D-COSY, nuclear magnetic spectroscopy and mass spectrometer 


























         9H-furo[3,2-f]chromene 
 
Figure 3.3: (a) The Ball-and-stick model of Fc-8b. (b) Structure of compound 8b 
obtained from Mass spectrometry and NMR structural analysis (1H, 13C and 2D 
COSY NMR). Atom numbering differs from usual furobenzochromone 
numbering 
Chemical formula: C11H8O2 
Exact mass: 173.1 
Molecular weight: 172.18 
Composition: C (76.73%), H (4.68%), O (18.58%) 
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3.4.1 ESIMS, 1H, 13C, 2D-COSY NMR studies of FC-8b 
Compound Fc-8b (Fig. 4) was obtained as a yellow powder. The ESIMS of 
Fc-8f showed a quasimolecular ion [M + Na]+ at m/z 173.1, indicating the elemental 
formula C11H8O2. This evidence, together with UV absorption bands at 254 nm, 
suggested the presence of a coumarin skeleton. The 1H NMR spectrum showed 
resonances suggesting a disubstituted aromatic ring. In the 1H and 13C NMR spectra 
of Fc-8b (Table 3.4), two carbons (δC128.2 and 128.4) and three protons [δH, 
5.98(1H, m), 6.88(1H dd), 4.61(2H,d)] in the B ring of the Chromene moiety were 
found, which were assigned as C-9, C-10, H-14, H-15 and H-16, respectively. The 
neighbouring groups were further confirmed using 2D-COSY technique (Appendix) 
In addition, proton signals for an aromatic moiety [δH 6.66 (1H,d), 7.52 (1H, d)] and, 
as well as a carbon signal at δC 147 and 116.2, were obtained, which gave evidence 
for furan ring in the structure. Therefore, the structure of Fc-8b was deduced as 
having a furan and a chromene moiety. On the basis of above the structure is 







































Figure 3.4: (a) The ball-and-stick model of Fc-8f. (b) Structure of compound 8f 
obtained from Mass spectrometry and NMR structural analysis (1H, 13C and 2D 
COSY NMR). Atom numbering differs from usual furobenzochromone 
numbering 
Chemical formula: C16H20O5 
Exact mass: 336.10 
Molecular weight: 336.34 
Composition: C (71.42%), H (7.49%), O (23.78%) 
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3.4.2 ESIMS, 1H, 13C, 2D-COSY NMR studies of FC-8b 
Compound Fc-8f was obtained as a yellow powder, and its molecular formula 
was determined as C16H20O5 by MS analysis, which showed a quasimolecular ion [M 
+ Na]+ at m/z 336.34. The
 
UV, 1H NMR, and 13C NMR spectroscopic data of Fc-8f 
(Table 2) were very
 
similar to those of Fc-8b. The proton signals on carbon C-9 and 
C-10 [δH, 6.91(1H, d), 6.93(1H d) had a slight downfield shift due to the presence of 
the carbonyl group on carbon C-8. The δC of C-8 was found at 156Hz, thus 
confirming the coumarin moiety of the structure. The proton and the carbon signals of 
the furan ring were observed at δH, 7.10(1H,d), 7,74(1H,d),  δC 110.9 and 145.7 for 
C-11 and C-12 respectively. In addition a O-ethoxy, methoxy benzene ring was 
deduced at position 1 on the benzene ring. The δC of C-14, C-15, C16 were found to 
be 128.8, 146.6, 140.7 respectively. Thus the compound Fc-8f was found to be (4´-
ethoxy, 5´-methoxy)-1-benzene furo[3,2-f]coumarin (Figure 3.5). The ESIMS, 1H, 











Table 3.4: 1H and 13C NMR (CH3OD, 300 and 125 MHz) Data of Fc-8b and Fc-8f 
compounds 
Compound 8b Compound 8f 
δ 1H NMR, 
mult (Hz) δ13C NMR 
δ 1H NMR,  
mult (Hz)       δ13C NMR 
C1 7.01,d 112.3 126.7 
C2 128.2 126.9 
C3 142.2 145.5 
C4 143 134 
C5 116.2 122.4 
C6 7.04,dd,1H 123.9 7.63,s,1H 114.7 
O7 
C8 4.61,d,2H 71.23 156 
C9 5.98,m,1H 128.2 6.91,d,1H 114.9 
C10 6.88,dd,1H 128.4 6.93,d,1H 127.4 
C11 6.66,d1,H 147 7.10,d,1H 110.9 





C17 7.16,d,1H 114.1 
C18 7.48,m,1H 121.1 
C19 7.13,d,1H 120 
O20 
O21 
C22 3.37,s,3H 56.6 
O23 
C24 3.98,t,3H 75.4 
C25 1.27,q,2H 18.6 
42 
 
3.5 Investigation on Activity of Selected Compounds on Human Skin Cells 
3.5.1 MTS based assay of Fc-8b on primary human skin fibroblast cells.   
MTS-based proliferation assay was performed by treating 106 human primary 
skin fibroblast cells with three different concentrations of compound Fc-8b: 5µM, 
10µM and 20µM. The MTS assay was carried out after 24, 48 and 72hrs of treatment 
time respectively. Bars represent mean +SD from n=3 independent replicates. DMEM 
–FCS, -Fc Compounds, and +DMSO was used as negative control and DMEM 
containing 10% FCS (v/v) + DMSO as positive control. The treated cells are 
significantly different (p< 0.01) from the negative control. The experiment was 
repeated at least 5 times. The result of one representative experiment is shown here. 
 
Figure 3.5: MTS-based Proliferation Assay on Human Skin Fibroblast Cells 


































3.5.2 MTS based assay of Fc-8f on primary human skin fibroblast cells.   
 MTS-based proliferation assay was performed by treating 106 human 
primary skin fibroblast cells with three different concentrations of compound Fc-8b: 
5µM, 10µM and 20µM. The MTS assay was carried out after 24, 48 and 72hrs of 
treatment time respectively. Bars represent mean +SD from n=3 independent 
replicates. DMEM –FCS, -Fc Compounds, and + DMSO was used as negative control 
and DMEM containing 10% FCS (v/v) as positive control. The treated cells are 
significantly different (p< 0.01) from the negative control. The experiment was 
repeated at least 5 times. The result of the best set is shown here. 
 
 
Figure 3.6: MTS-based Proliferation Assay on Human Skin Fibroblast Cells 

































MTS assay is a quantitative and sensitive spectrophotometric assay for 
determining viability and proliferation of cultured cells. Since extracts from P. 
corylifolia are used in treatment of various skin diseases (Uriarte E, 2005) we tested 
the compounds on skin fibroblasts. Based on the hydrophobic nature of the 
compounds Fc-8b and Fc-8f, they were dissolved in DMSO solvent and applied to 
cells. Blank controls were set up to ensure that DMSO does not cause any 
proliferation or toxic effects on cells. In the negative controls (DMEM only and 
DMEM + DMSO), cells were less dense as compared to positive control (DMEM + 
10% FCS), as expected. Cells treated with compound Fc-8b (DMEM lacking FCS) 
showed similar proliferation effects as produced by FCS containing DMEM. Both 
treatments led to higher density of cells, as compared to negative controls. When 
comparing densities of cells treated with different concentration of compound Fc-8b 
(5µM, 10µM and 20 µM), no significant differences were observed. Hence, the lowest 
concentration was highly active. Skin cells grown in medium containing 5µM of 
compound Fc-8b, 10µM, and 20µM of compound Fc-8b showed approximately the 
same level of proliferation as compared to cells grown in medium containing 10% 
FCS in 24hrs. Cells treated with Fc-8b showed 2 times more proliferation activity 
compared to cells growing in wells containing DMEM in 48 and 72hrs respectively. 
Hence, compound Fc-8b has very significant proliferation-inducing effects on human 
skin fibroblast cells.  
As compared to the activity of Fc-8b, skin fibroblast cells growing in medium 
containing 5µM, 10µM, and 20µM of compound Fc-8f induced approximately the 
same level of cell proliferation as cells grown in 10% FCS in 24hrs. Activity of Fc-8f 
in comparison with negative control increased slightly more than 2 fold after 72hrs of 
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treatment. Fc-8f is also more active at lower concentration (5µM) when compared to 
10µM, and 20µM. 
3.5.3: Concluding Remarks! 
We report that the effects of small molecules with novel therapeutic potential 
from seeds of a traditional medicine plant source. P. corylifolia seeds with simple 
combination of preparative RP-HPLC and preparative TLC techniques yielded 
sufficient amount of pure compounds whose structures were deduced to be Fc-8b (1) 
9H-furo[3,2-f]chromene and Fc-8f (2) (4´-ethoxy, 5´-methoxy)-1-benzene furo[3,2-
f]coumarin. 
 Both metabolites are active at 5µM concentration on human primary skin 
fibroblast cells with some difference in their duration and extent of action. The result 
may be attributed to their structure. The furanochromene seems more active than the 
furanocoumarin derivative form of the compounds and will be helpful in synthesizing 
analogues. No effects are seen on pigmentation or any other phenotypically visible 
traits of cell cultures.  
It is noteworthy that both the Fc-compounds can induce proliferation in the 
absence of any other growth factor in the medium such as FCS. The increase in 
proliferation of skin cells is comparable to effects produced by fetal calf serum (FCS) 
in case of Fc-8b (1) and slightly more in FC-8f (2). Furanochromenes and their 
natural and synthetic derivatives, therefore, might have potential applications (i) 
creating synthetic (serum-free) culture media; (ii) anti-ageing cosmetics industry; and 












Results & Discussion 
Synthesis and characterisation of 
Furanocoumarin derivatives and their 








4.0 Introduction  
In organic synthesis, some simple approaches can lead to consequences of 
significant importance in both the strategy and design of simple organic molecules. 
The addition of an aromatic ring to alkenes or alkynes to form C–C bonds via C–H 
functionalization provides efficient and atom-economic synthetic methods. This C–C 
bond formation forms the basis for the synthesis of a large number of heterocycles. 
The participation of alkynyl coumarins in Pd-catalyzed cyclo functionalization 
process was first investigated by Pd-catalyzed cross-coupling. The key step 
(Sonogashira coupling) in a Pd-catalyzed cross-coupling reaction is between the iodo 
derivative and appropriate alkyne. Another example involves, Intramolecular 
hydroarylation, a formal addition of arene C–H bonds across multiple bonds, provides 
a direct route to valuable organic compounds such as annulated arenes, heterocycles, 
and carbocycle (Kenny R.S. et al, 2006). In contrast to the Heck reaction, a 
hydroarylation approach eliminates the requirement of a halogen (or triflate) 
substituent, which is also a feature of other routes (Murai, S. et al, 2000). The 
alternative routes include arene in a Sonogashira type of addition, multiple bond 
activation, electrophilic substitution, and metal-catalyzed Claisen rearrangement 
(Ellman, J. A et al, 2001). The compatibility of palladium catalyst on the cyclization 
of alkyne substrates, specifically propargyl–aryl ethers and alkene–aryl ethers, by 
multiple bonds activation–electrophilic substitution has been studied (Sames, D. et al. 
2003, 2004).  
Keeping these theoretical aspects in mind we developed a novel synthetic 
route to synthesize furanocoumarin analogues. Here, we decided to use bromo 




4.1 Rationale behind the synthesis of Furanocoumarin compounds. 
 We observed from the previous Chapter that Fc-8b is a Furanochromene and 
Fc-8f is a Furanocoumarin, respectively. Both show similar bioactivity on human 
primary skin cells. These two compounds also share the same chromophore with the 
difference being the presence of oxygen atom on the 6th carbon atom for 
furanocoumarin. Figure 4.1 highlights the basic difference between these structures. 
We have established a synthetic route that would synthesise the basic chromophore. 
Additional derivatives were synthesized by changing the secondary reactant in the 
Sonogashira coupling step. The rationale to test out the activity of different 





Figure 4.1: Difference between Furanocoumarin and Furnochromene  
4.2 The synthetic scheme for Fc-compounds  
A modified (new) scheme for furanocoumarin synthesis was developed. The 
novelty of this method is that, furanocoumarin derivatives can be synthesized in three 
simple steps compared to the complicated 7-8 steps in previous reports (Ronald et al, 
1982 and Raffaele Tabacchi et al, 2005).  In order to avoid the formation of side 
products during Sonogashira coupling reaction, the hydroxyl group at the ortho 
position of the aldehyde has to be protected. The usual protection group used is MOM 
(methoxy methyl ether). The MOM group was used to protect hydroxyl groups as in 
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the syntheses of siccayne (Zamerlik, H et al. 1990), eutypine, (Tabacchi, R. et al, 
1993) and, sterehirsutinal (Tabacchi, R. et al, 1999) that include a Sonogashira 
reaction for the acetylenic side chain introduction. 
4.2.1 Michael addition reaction to synthesize the coumarin moiety 
An alternative approach compared to general use of protecting groups like, 
MOM etc. to synthesize furanocoumarin adduct was considered here. Instead of 
protecting the ortho-OH group Michael addition reaction was used which involved an 
active carbanion such as Diethylmalonate (nucleophile) and 2,4-dihydroxy 
benzaldehyde as the electrophile. The yield of this reaction was 97% (w/w) of the two 
starting materials.  
DEM, Piperidine








Figure 4.2: Michael addition reaction showing the formation of coumarin 
   
This step ensured that the ortho-OH group was protected. Simultaneously, the 
six membered coumarin moiety was also synthesized.  The presence of the ethoxy 
acetate group facilitated a directed bromination. The formation of the ethoxy 
substituted coumarin was confirmed by ESI-MS m/z: 234.2, 1H, 13C NMR 
spectroscopy. (Spectra are provided in Appendix)  
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4.2.2 Directed bromination using Br2/AcOH 
The second step is known as directed bromination (Alvim Jr et al., 2005). This 

















Figure 4.3: Bromination of ethoxy coumarin (product from step one) 
  
Due to the presence of ethoxy group ortho to the carbonyl group, the bromine 
group can be attached either at position 6 or 8. This is because of the e- withdrawing 
effect of ethoxy group. Due to this effect, positions 6 and 8 are e- deficient, 
facilitating the nucleophile Br- to attach. Thus, this reaction is termed as “directed 
bromination”. Since coumarin and bromine were mixed in 1:1(w/w) ratio, as expected 
both positions were brominated.  





4.2.3 Sonogashira coupling 
The third step and the final is the standard Sonogashira coupling reaction. In 
this reaction, typically two catalysts are used in this reaction: a zero valent palladium 
catalyst and a halide of Copper (1) salt. The palladium complex activates the organic 
halides by oxidative addition into the carbon-halogen bond. Phosphine-palladium 
complexes such as tetrakis (triphenylphosphine) palladium(0) are used for this 
reaction. However, palladium(II) complexes are also available because they are 
reduced to the palladium(0) species by the consumption of terminal alkynes in the 
reaction medium. The oxidation of triphenylphosphine to triphenylphosphine 
oxide can also lead to the formation of Pd(0) in situ, when catalysts such 
as bis(triphenylphosphine)palladium(II) chloride are used. In contrast, copper (I) 
halides react with the terminal alkyne and produce copper(I) acetylide, which acts as 
an activated species for the coupling reactions. 
More often an iodo-substituted reactant is used as the starting material for the 
coupling reaction. Here, we used a bromo-substituted coumarin derivative. The 
reaction yielded 60% of furanocoumarin products (Figure 4.3). The ESIMS, 1H, 13C 























Figure 4.4: Sonogashira coupling reaction 
 
The coupling product depends on the alkyne reactant (highlighted in blue). 
Other reagents such as, TMSA (trimethyl silyl acetylene) and TPSA (triphenyl silyl 
acetylene) were used as reactants respectively to form the furan rings. But the 
reactions were not successful. This may be because tertiary-silyl group is a very good 
leaving group. At reflux conditions like 110oC, the tertiary-silyl group will be easily 
cleaved, making the formation of furanocoumarin unstable. We postulate that, 
triphenylsilyl acetylene, wouldn’t also be suitable for the formation of the furan ring, 
because of steric hindrances caused by bulky triphenyl group.  The use of tert-butyl 
acetylene was successful. The presence of the tert-butyl group stabilizes the formation 
of the furan moiety. Thus, we synthesised two new furanocoumarin compounds, 
which are derivatives of furanocoumarin class of compounds.     
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4.2.4 The combined scheme to synthesize Fc-derivatives  
The synthetic route described here for the preparation of the Fc-derivatives is 
based on the condensation of 2,4-dihydroxybenzaldehyde with Meldrum’s acid or 
diethyl malonate, followed by bromination reactions. The synthetic pathway consists 
of building the tricyclic nucleus via Sonogashira coupling reaction. As shown in the 
scheme 1,  
2, 4-dihydroxybenzaldehyde (1) is reacted with diethylmalonate (2) to yield, 
ethoxy-7-hydroxyaminocoumarin-3-ate (3). Reactants are further subjected to directed 
bromination with bromine and acetic acid. The bromination is seen in two specific 
positions namely 6 (4) and 8 (5). Compounds 5 and 6 are coupled with 2-methylbut-1-
en-3-yne using the Sonogashira catalyst. The products are 2-tert-Butyl-7-oxo-7H-
furo[3,2-g]chromene-6-carboxylic acid ethyl ester (5) and  8-tert-Butyl-2-oxo-2H-
furo[3,2-h]chromene-3-carboxylic acid ethyl ester (6). The details of the structure are 
given in Figures 4.5 and 4.6 respectively, below. The peak assignments of 1H and the 









































Figure 4.5: Three step synthetic scheme for total synthesis of Fc-derivatives. The 





               
   



























2-tert-Butyl-7-oxo-7H-furo[3,2-g]chromene-6-carboxylic acid ethyl ester
 
 
Figure 4.6: (a) The ball-and-stick model of Syn1 (5). (b) Structure of synthetic 
compound Syn1 (5) obtained from mass spectrometry and NMR spectra (1H, 
13C).  
Chemical formula: C18H18O5 
Exact mass: 314.12 
Molecular weight: 314.33 




4.3 Structural elucidation of Syn1 and Syn2  
4.3.1 ESIMS, 1H, 13C, 2D-COSY NMR studies of Syn1 (5) 
Fc-compound Syn1 (5) was obtained as a yellowish brown amorphous 
powder. The ESIMS of Syn1 (5) showed a quasimolecular ion [M + Na]+ at m/z 
314.1, indicating the elemental formula C18H18O5 This evidence, together with UV 
absorption bands at 254 nm, suggested the presence of a coumarin skeleton. The 1H 
NMR spectrum showed resonances suggesting a disubstituted aromatic ring. In the 1H 
and 13C NMR spectra of Syn1 (Table 2), the carbon signal at δC 162 indicates the 
presence of carbonyl and the δH, 8.65(1H, s) confirms the presence of coumarin 
moiety in the structure. In order to confirm the successful formation of the furan ring 
(end product of Sonogashira coupling reaction) a δH signal at 6.75(1H, s) must be 
evident. This along with δC 99.1 confirms the presence of furan moiety in the 
structure.  (δC29.1) and three protons [δH, 1.36(3H, s), which were assigned as C-9, 
C-10, and C-11, 3H-9, 3H-10 and 3H-11, of the tertiary butyl group respectively. In 
addition, proton signals for an aromatic moiety [δH 7.67 (1H,s), 7.37 (1H, s)] and, as 
well as a carbon signal at δC 119.7 and 104.6, were obtained. Together, these gave 
evidence for presence of disubstituted benzene ring in the structure. The ethoxy ester 
substituent on carbon 5 was evident from the presence of a carbonyl signal at δC 165 
and [δH, 4.43(2H, q) and 1.3(3H,t)] Therefore, the structure of Syn1 (5) was deduced 
as having both furan and coumarin moieties. On the basis of above, the complete 






                      
 

























8-tert-Butyl-2-oxo-2H-furo[2,3-h]chromene-3-carboxylic acid ethyl ester
 
Figure 4.7: (a) The ball-and-stick model structure of Syn 2 (6). (b) Structure of 
compound Synthetic Syn 2 (6) obtained from Mass spectrometry and NMR 
spectra (1H, 13C)  
Chemical formula: C18H18O5 
Exact mass: 314.12 
Molecular weight: 314.33 




4.3.2 ESIMS, 1H, 13C, 2D-COSY NMR studies of Syn 2 (6) 
Compound Syn2 (6) was also obtained as a yellowish brown amorphous powder. 
The ESIMS of Syn1 (6) showed a quasimolecular ion [M + Na]+ at m/z 314.1, 
indicating the elemental formula C18H18O5. This is an expected as Syn2 (6) is an 
isomer of Syn1 (5). Due the directed substitution bromine in (3) Syn2 (6) is the 
angular derivative of Syn1 (5). This evidence, together with UV absorption bands at 
254 nm, suggested the presence of a coumarin skeleton. The 1H NMR spectrum 
showed resonances suggesting a disubstituted aromatic ring. In the 1H and 13C NMR 
spectra of Syn2 (Table 2), the carbon signal at δC 162 which is the same as Syn1 (5) 
indicates the presence of carbonyl and the δH, 8.64(1H, s), δC 152.6 confirms the 
presence of coumarin moiety in the structure. In order to confirm the successful 
formation of the furan ring in this isomer we have to look for a δH signal at 7.26(1H, 
s) which must be evident. This along with δC 166.2.1 confirms the presence of furan 
moiety in the structure. The downfield shift in the δH and δC signals is attributed to 
the angular nature of the structure.  δC29.1 and three protons [δH, 1.36(3H, s), which 
were assigned as C-17, C-18, and C-19, 3H-17, 3H-18 and 3H-19, of the tertiary butyl 
group respectively. In addition, proton signals for an aromatic moiety [δH 7.38 
(1H,d), 7.68 (1H, d)] and, as well as a carbon signal at δC 108.5 and 122.7, were 
obtained, Together, these gave evidence for presence of disubstituted benzene ring in 
the structure. Therefore, the structure of Syn2 (6) was deduced as having both furan 
and coumarin moieties. On the basis of above, the complete structure is represented in 
Figure 4.7 





Table 4.1: 1H and 13C NMR (CH3OD, 300 and 75 MHz) Data of Synthetic (5) Syn 
1 and (6) Syn 2 compounds 
Synthetic Compound 1 Synthetic 
Compound 
2 
δ 1H NMR, mult 
(Hz) δ13C NMR 




C1 166.2 C1 122.5 
C2 6.75,s,1H 99.1 C2 162 
C3 124.6 C3 120.7 
C4 8.65,s,1H 152.6 C4 152.8 
C5 122.2 C5 7.38,d,1H 108.5 
C6 162 O6 
O7 C7 1.32,t,3H 13.7 
C8 7.67,s,1H 119.7 C8 4.32,q,2H 59.8 
C9 1.36,s,3H 29.7 O9 
C10 1.36,s,3H 29.7 C10 165 
C11 1.36,s,3H 29.7 O11 
C12 38.3 C12 8.64,s,1H 152.6 
O13 O13 
C14 122.5 C14 162 
C15 1.3,t,3H 13.7 O15 
C16 4.43,q,2H 59.6 C16 7.68,d,1H 122.7 
C17 146.9 C17 1.34,s,3H 29.7 
O18 O18 1.34,s,3H 29.7 
C19 7.37,s,1H 104.6 C19 1.34,s,3H 29.7 
O20 152.8 C20 38.3 
C21 165 C21 7.26,s,1H 166.2 




4.4 Investigation on Activity of Syn1 (5) and Syn2 (6) compounds on skin 
fibroblast Cells 
4.4.1 MTS based assay of Syn1 (5) on primary human skin fibroblast cells.   
MTS-based proliferation assay was performed by treating 106 human primary 
skin fibroblast cells with three different concentrations of compound Syn1 (5): 5µM, 
10µM and 20µM. The MTS assay was carried out after 24, 48 and 72hrs of treatment 
time respectively. Bars represent mean +SD from n=3 independent replicates. The 
experiment was repeated at least 5 times. The result of the best set is shown here.
 DMEM –FCS, -Syn-compounds and +DMSO was used as negative control 
and DMEM containing 10% FCS (v/v) + DMSO as positive control. Treated cells are 
significantly different (p< 0.01) from the negative control.  
 
 
Figure 4.8: Effect of Syn1 (5) on proliferation of human skin fibroblast cells 



































4.4.2 MTS based assay of Syn2 (6) on primary human skin fibroblast cells. 
MTS-based proliferation assay was performed by treating 106 human primary 
skin fibroblast cells with three different concentrations of compound Syn2 (6): 5µM, 
10µM and 20µM. The MTS assay was carried out after 24, 48 and 72hrs of treatment 
time respectively. Bars represent mean +SD from n=3 independent replicates.  
DMEM –FCS, -Fc-compounds and +DMSO was used as negative control and 
DMEM containing 10% FCS (v/v) + DMSO as positive control. The results shown in 
Figure 4.9 clearly show that Syn2 (6) is not active in inducing proliferation of skin 
fibroblast cells. 
   
 
Figure 4.9: Effect of Syn2 (6) on proliferation of human skin fibroblast cells 
































Similar to the Fc-8b and Fc-8f (compounds from P. Corylifolia seed extracts) 
Syn1 (5) and Syn2 (6) were tested for bioactivity on skin fibroblast cells. As these 
compounds do not dissolve in water, DMSO was used as the solvent. Blank controls 
were set up to ensure that DMSO does not cause any proliferation or toxic effects on 
cells. As expected, in the negative controls (DMEM only and DMEM + DMSO), cells 
were less dense as compared to positive control (DMEM + 10% FCS). In case of 
Syn1 (5), proliferation of cells were observed at 24hr time point itself. In comparison 
with Fc-8b and Fc-8f (Compounds isolated from P. corylifolia) Syn1 (5) was found to 
be more active at both 24hr and 48hr time point at 5µM concentration. The cells 
treated with compound Syn1 (5) (DMEM lacking FCS) showed similar proliferation 
effects as produced by 10%FCS containing DMEM at 48 and 72hrs respectively. But 
at 24hr time point cells treated with compound Syn1 (5) showed more proliferation 
compared to cells treated with DMEM + 10% FCS. Both treatments led to higher 
density of cells, as compared to negative controls. Activity of Syn1 (5) in comparison 
with negative control increased slightly less than 2-fold after 72hrs of treatment. The 
activity was consistent with lower concentrations (5µM and 10µM) with respect to 
24hr and 48hr but the activity reduced to some extent at higher concentrations (20µM) 
at 72hrs.   






4.4.3 MTS-based assay of combined Fc-8b, Fc-8f, Syn1 (5), on primary human 
skin fibroblast cells.   
 
In none of the experiments described thus far the natural and synthetic 
compounds were compared directly. In order to compare natural vs synthetic on equi-
molar basis, therefore, a new set of experiments were performed. This plot compares 
the proliferation activity of the three active compounds. Two of which are isolated 
from the P. corylifolia seeds (Fc-8b and Fc-8f) and one synthesized compound Syn1 
(5).  All the three compounds induce proliferation of skin fibroblast cells with a two-
fold difference, when compared to the negative control. The order of activity after 
24hr treatment time was Syn1>Fc-8b~Fc-8f. After 72hr of treatment, the order of 
activity was Fc-8b>Fc-8f>Syn1. Hence Syn1 (5) acts faster and induces proliferation 
to similar levels over a period of time, whereas Fc-compounds acts slower but lead to 
slightly higher proliferation of cells. 
 
Figure 4.10: Effect of Fc-8b, Fc-8f, and Syn1 (5) on proliferation of human skin 
































4.5 Imaging of nucleus of stained cells treated with Fc-compounds 
  PI staining was used to visualise nuclei of cells treated with Fc-compounds 
(Figure 4.11 and 4.12 show images of 48 and 72 hrs time points). Nuclei were 
visualised to determine whether the compounds induced nuclear division or not. In 
comparison with bright field images these would distinguish whether the compounds 
induced cell or nuclear proliferation. Propidium iodide (PI) binds to DNA by 
intercalating between the bases (guanine and cytosine) with little or no sequence 
preference and with a stoichiometry of one dye per 4–5 base pairs of DNA. Once the 
dye is bound to nucleic acids, its fluorescence is enhanced 20- to 30-fold, the 
fluorescence excitation maximum is shifted ~30–40 nm to the red and the 
fluorescence emission maximum is shifted ~15 nm to the blue. DNA in the nucleus 
appears red under the green-yellow or blue excitation (568- or 488-nm laser 
excitation, respectively), and immunosignals are observed as green fluorescence 
under blue excitation (488-nm excitation) 
Cells were grown on coverslips and synchronized by starving for 24hrs. Then, 
they were treated with 5µM concentration of the drug Fc-8b, Fc-8f and Syn1. FCS 
containing DMEM was treated as the positive control and DMEM lacking FCS was 
treated as negative control. PI-stained sections of the coverslips were examined under 
the confocal microscopy.  
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Figure 4.11: Confocal laser showing images of PI-stained skin fibroblast cells. (a) 
Cells treated with DMEM lacking FCS (b) Cells treated with DMEM+10% FCS. 
Cells treated for 48hr with (c) 5µM Fc-8b (d) 5µM Fc-8f (e) 5µM Syn1. These 





                             
                                                       
                                                     
Figure 4.12: Confocal laser showing images of PI-stained skin fibroblast cells. (a) 
Cells treated with DMEM lacking FCS (b) Cells treated with DMEM+10% FCS. 
Cells treated for 72hr with (c) 5µM Fc-8b (d) 5µM Fc-8f (e) 5µM Syn1. These 







Images were taken at different sections of the coverslips. One section of the 
cover slip of cells treated with Fc-8b, Fc-8f and Syn1 compounds are shown above. 
The images show sparse density of cells in the negative control, which is due to the 
absence of growth factors in the medium. Whereas, the density of cell treated with the 
drugs are increased. These results correlate the findings of enhanced proliferation of 




































4.6 Investigation on molecular effects of compound Fc-8b, Fc-8f and Syn1 on skin 
fibroblast  
 
Two of the most popular flow cytometric applications are the measurement of 
cellular DNA content and the analysis of the cell cycle. 
 
4.6.1 Flow Cytometry Measurement of Cellular DNA Content 
The nuclear DNA content of a cell can be quantitatively measured at high 
speed by flow cytometry. Initially, a fluorescent dye that binds stoichiometrically to 
the DNA is added to a suspension of permeabilized single cells or nuclei. The 
principle is that the stained material results from binding dye fluorescent proportional 
to the amount of DNA. The stained DNA is then measured in the flow cytometer and 
the emitted fluorescent signal yields an electronic pulse with a height (amplitude) 
proportional to the total fluorescence emission from the cell. Thereafter, such 
fluorescence data are considered a measurement of the cellular DNA content. 
The key to understanding the real mechanism of action of the drug is to 
analyse the cellular and molecular level changes. We first analysed which phase of the 
cell cycle is being triggered to induce rapid proliferation of skin fibroblasts. 
Performing the experiment in triplicates increases the confidence in the data due to 
increased sample size and reduces the chances of error due to chance. The control 
samples in this study were non-treated cells. However, the control samples were 
treated with the same quantity of DMSO used in the dilution of the drug. This process 
subtracts the background observed due to DMSO.  
Measurements were after 24, 48 and 72hrs of treatment with the three 
compounds in triplicate samples. Stained cells with PI were analysed by flow 
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Figure 4.13: PI stained flow cytometry assay of human skin fibroblast cells 
(NF103, P10) after 24hr treatment with compounds Fc-8b, Fc-8f, and Syn1 
respectively.  
 
Flow cytometry assay was performed by treating 106 human primary skin 
fibroblast cells with three different compound Fc-8b, Fc-8f and Syn at concentration 
5µM. The measurement was carried out after 24hrs of treatment time. Bars represent 
mean +SD from n=3 independent replicates. DMEM without FCS and Fc-compounds 
was used as negative control and DMEM containing 10% FCS (v/v) as positive 





















Figure 4.14: PI stained flow cytometry assay of human skin fibroblast cells 
(NF103, P10) after 48hr treatment with compounds Fc-8b, Fc-8f, and Syn1 
respectively.  
 
Flow cytometry assay was performed by treating 106 human primary skin 
fibroblast cells with three different compound Fc-8b, Fc-8f and Syn at concentration 
5µM. The measurement was carried out after 48hrs of treatment time. Bars represent 
mean +SD from n=3 independent replicates. DMEM without FCS and Fc-compounds 
























Figure 4.15: PI stained flow cytometry assay of human skin fibroblast cells 
(NF103, P10) after 72hr treatment with compounds Fc-8b, Fc-8f, and Syn1 
respectively.  
 
Flow cytometry assay was performed by treating 106 human primary skin 
fibroblast cells with three different compound Fc-8b, Fc-8f and Syn at concentration 
5µM. The measurement was carried out after 72hrs of treatment time. Bars represent 
mean +SD from n=3 independent replicates. DMEM without FCS and Fc-compounds 























4.6.2 Flow Cytometry analysis of the Fc-Compounds and Syn1 (5) 
In order to synchronize the cells at the start of treatment with drugs, they were starved 
for 24hrs during pre-treatment. Upon the treatment with the compounds, proliferations 
of the cells were triggered at the G2/M phase of the cell cycle (Figure 4.16). This is 
consistent with the positive control.  Compared to the negative control, there is a wide 
difference in all the phases of the cell. This is as expected because of the absence of 
any growth factors in the negative control.  There is a gradual decrease in the number 
of cells in G2/M and S phase at the 48hr and 72 hr time point. This can be due to the 
reducing activity of the drugs as time progresses. During 48 and 72hrs more cells are 
observed to move to G1 phase of the cell cycle.  The overall conclusion of the results 
is that the drugs act similar to the positive control by triggering the G2 phase of the 
cell cycle to rapidly induce cell proliferation. All the drugs trigger the cell cycle via 
G2/M phase of the cell cycle 
 Figure 4.16 shown below clearly indicates that the drugs trigger the 
proliferation mechanism via the G2/M phase of the cell cycle. It is observed that there 
is no significant difference seen in the G1 phase whereas, there is 20% increase in G2 












Figure 4.16: Cell Cycle regulation by Fc-8b, Fc-8f and Syn1: Propidium iodide 
based flow cytometric assay of cell cycle indicated divergent effects of Fc-8b, Fc-
8f and Syn1 on skin fibroblast cells. The phase and time-points at which the drug 














































































5.1 Significance and final conclusion: 
5.1.1 Stages of cell cycle 
The cell cycle is regulated by three main check points highlighted by oval in 
figure 4.15. From the flow cyctometer results it is evident that these compounds 
induce proliferation in the skin cells via the G2/M checkpoint. The main regulators of 
this phase are cyclin A and cyclin B (Table 5.1). These cyclins and Cdks work in 
combination with each other (Figure 5.1). The proliferation of the cell cycle is known 
to be under the control of these cyclin-Cdks complexes. It is likely that Fc-compounds 
may directly or indirectly affect the activity of cyclin-cdk complex. This can be tested 




















































































5.1.2: The Natural world: 
  Two novel metabolites Fc-8b and Fc-8f have been successfully 
isolated and purified up to 99% from Psoralea corylifolia seeds. Different analytical 
methods were used such as, Reverse Phase- High Performance Liquid 
Chromatography, Flash and preparative Thin Layer chromatography. Structures were 
elucidated using mass spectrometer and 1H, 13C and 2D-COSY NMR spectroscopy 
and their bioactivity was investigated on primary human skin fibroblast cells.  The 
natural products Fc-8b which is a novel furanochromene structure has been reported 
for the first here. Both Fc-metabolites induce proliferation at levels similar to those 
induced by universal standard fetal calf serum (FCS). Therapeutically, this has at least 
the following three applications 1) Fc-compounds can be used to create complete 
synthetic cell culture media 2) These drugs can be tested in skin regeneration 
processes in cosmetic industry. 3) They can used in the wound healing processes 
which requires increased proliferation of cells.  One such possible application of this 
is in the healing of diabetic wounds. The disadvantages of these molecules being a 
drugs are that, the concentrations of the compounds are 50ppm of the active principle 
which is very low concentration. This in turn will require large amounts of seed to 
extract large quantity of compounds. The extractions and purification techniques 
becomes more tedious and complicated in handling large quantities.  
 
5.1.3: Link to the Synthetic world: 
Some of disadvantages mentioned of the natural products can be overcome 
using synthetic approach. In an attempt to synthesize the Fc-compounds new targets 
were hit. Firstly, a very simple, three-step synthesis of furanocoumarins was 
established. The key step is the Sonogashira coupling reaction. The complete 
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synthesis of two new furanocoumarin was done. Curiously, these compounds were 
tested for their activity and one of the compound Syn1 (5) had the same level of 
proliferation effect as the natural Fc-compounds. Other compound Syn2 (6) tested 
here didn’t not show any proliferation activity. This may be due to the structural 
aspects of the compound Syn2 (6). Moreover, the synthetic scheme allows us to easily 
synthesize different derivatives of furanochromene and furanocoumarin derivatives. 
The other advantages of the synthesis derivatives are that,  
1. Large quantities can be easily synthesized.  
2. More active compounds can be synthesized by modifying the side chains of 
these molecules keeping the basic chromospheres constant.  
3. These compounds are more stable and have longer shelf life than natural 
products. 
5.1.4: Cellular effects of active compounds 
The discovery of three new compounds having similar effect has been 
established. The next question to be answered would be: how are these classes of 
compounds triggering the proliferation of skin fibroblast cells? Thus, initial molecular 
studies were done with flow cytometry which showed that the G2/M phase of the cells 
is being triggered by the application of these compounds. This result was consistent 
with similar action shown by the universal standard fetal calf serum (FCS). This 




















This project can be taken into two significant and different directions 
6.1 Directions 1: Organic synthesis of Fc-derivatives 
The synthetic method that has been established is novel. This is because by 
modifying the acetylene reactant in the Sonogashira coupling step, many derivatives 
of these classes of compounds can be synthesised. This makes it easy to synthesis a 
library of compounds and screen for their bioactivity. By changing the R-group on the 





















R1: -OCH3, -Si(CH3)3, -OCOCH3, -OCOC2H5, -NH2 etc.
R2: -OH, -NH2, OCH3, OC2H5 etc.
   
 Figure 6.1: Derivatives that can be synthesised  
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6.2 Direction 2: Studies on mechanism of action 
Now that the drugs are found to have a significant activity, the mechanism of 
action becomes very interesting. The flow cytometer results of these compounds shine 
some light on the path the drugs may be acting. We have seen that these compounds 
trigger the G2/M phase of the cell cycle.  
 
Figure 6.2: G2/M checkpoints of cell cycle. (Source: Biocarta)  
More molecular studies can be done to study the mechanism of action. The 
checkpoints of G2/M phase are cyclin B and cyclin A. The regulations of these 
cyclins can be the immediate experiments followed by the changes it leads to in the 
downstream and upstream processes.  
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     Mass spectrum (Q1) of Fc-8b shows m/z of 173.1 in ESI-MS positive mode 
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                    COSY-NMR (MeOD4) Spectrum of purified compound Fc-8b 
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  2D-COSY NMR (MeOD4) Spectrum of purified compound Fc-8b 













     


















































































































































































































































*** Processing Parameters ***
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Mass spectrum (Q1) of ethoxy-7-hydroxyaminocoumarin-3-ate (3) shows m/z of 234.0 in ESI-MS positive mode 
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Mass spectrum (Q1) of Syn1 (5) shows m/z of 314.1 in ESI-MS positive mode 
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Dot plots of PI stained cells treated DMEM lacking 10% FCS and DMEM with 10% FCS at 24hr time point 
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Dot plots of PI stained cells treated Fc-8b, Fc-8f and Syn1 (5) at 24hr time point 
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Dot plots of PI stained cells treated DMEM lacking 10% FCS and DMEM with 10% FCS at 48hr time point 
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Dot plots of PI stained cells treated Fc-8b, Fc-8f and Syn1 (5) at 48hr time point 
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Dot plots of PI stained cells treated Fc-8b, Fc-8f and Syn1 (5) at 72hr time point 
